OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00289559

Guizhou Chanhen Chemical Corp

Commodity ChemicalsVerified

Guizhou Chanhen Chemical Corp maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.4, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.14, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess liquidity. Free cash flow for the period was 520.19 million CNY, while operating cash flow was 641.90 million CNY, indicating the company generates positive cash from operations. Profitability metrics show that the company is performing well relative to its industry. Return on equity (ROE) stands at 16.35%, and return on assets (ROA) is 9.17%, both of which are strong indicators of efficient capital use and asset management. These figures suggest that the company is generating solid returns for its shareholders and effectively utilizing its asset base. The company's revenue is primarily concentrated in its domestic operations, with no disclosed international revenue segments. This geographic concentration may expose the company to regional economic and regulatory risks. The company operates a single business segment focused on the production and sale of commodity chemicals, which is typical for firms in the Commodity Chemicals industry. Looking ahead, the company is expected to maintain a stable growth trajectory. Analysts project a mean price target of 45.87 CNY, with a median of 47.34 CNY, and a high of 50.30 CNY. The mean recommendation is 1.60, indicating a generally positive outlook from analysts. The company's revenue history shows consistent performance, and the outlook for the current and next fiscal years is stable, with no significant growth or contraction expected. The company faces moderate liquidity risk, as noted in the risk assessment, with net cash being negative after subtracting total debt. However, the dilution risk is low, and there are no immediate signs of equity dilution. The company has not issued additional shares recently, and there are no indications of a near-term need for capital raising. The risk assessment also highlights the importance of monitoring the company's debt levels and cash flow generation to ensure continued financial stability. Recent events and disclosures indicate that the company has not experienced any major operational or financial disruptions. The company's latest financial filings and investor relations communications reflect a stable business environment. There are no recent earnings call transcripts or regulatory filings that suggest significant changes in the company's strategic direction or financial health. The company continues to operate within its core business model, with no major new initiatives or product launches disclosed.

30-day price · 002895-5.34 (-13.5%)
Low$33.88High$40.54Close$34.18As of15 May, 00:00 UTC
Profile
CompanyGuizhou Chanhen Chemical Corp
Ticker002895.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Guizhou Chanhen Chemical Corp is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. Guizhou Chanhen Chemical Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Guizhou Chanhen Chemical Corp maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.4, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.14, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess liquidity. Free cash flow for the period was 520.19 million CNY, while operating cash flow was 641.90 million CNY, indicating the company generates positive cash from operations. Profitability metrics show that the company is performing well relative to its industry. Return on equity (ROE) stands at 16.35%, and return on assets (ROA) is 9.17%, both of which are strong indicators of efficient capital use and asset management. These figures suggest that the company is generating solid returns for its shareholders and effectively utilizing its asset base. The company's revenue is primarily concentrated in its domestic operations, with no disclosed international revenue segments. This geographic concentration may expose the company to regional economic and regulatory risks. The company operates a single business segment focused on the production and sale of commodity chemicals, which is typical for firms in the Commodity Chemicals industry. Looking ahead, the company is expected to maintain a stable growth trajectory. Analysts project a mean price target of 45.87 CNY, with a median of 47.34 CNY, and a high of 50.30 CNY. The mean recommendation is 1.60, indicating a generally positive outlook from analysts. The company's revenue history shows consistent performance, and the outlook for the current and next fiscal years is stable, with no significant growth or contraction expected. The company faces moderate liquidity risk, as noted in the risk assessment, with net cash being negative after subtracting total debt. However, the dilution risk is low, and there are no immediate signs of equity dilution. The company has not issued additional shares recently, and there are no indications of a near-term need for capital raising. The risk assessment also highlights the importance of monitoring the company's debt levels and cash flow generation to ensure continued financial stability. Recent events and disclosures indicate that the company has not experienced any major operational or financial disruptions. The company's latest financial filings and investor relations communications reflect a stable business environment. There are no recent earnings call transcripts or regulatory filings that suggest significant changes in the company's strategic direction or financial health. The company continues to operate within its core business model, with no major new initiatives or product launches disclosed.
Key takeaways
  • Guizhou Chanhen Chemical Corp maintains a strong ROE of 16.35% and ROA of 9.17%, indicating efficient capital and asset utilization.
  • The company's debt-to-equity ratio of 0.4 suggests a conservative capital structure with limited leverage.
  • Analysts project a mean price target of 45.87 CNY, with a generally positive outlook (mean recommendation of 1.60).
  • The company's liquidity position is medium, with a current ratio of 1.14 and negative net cash after debt.
  • The company operates a single business segment focused on commodity chemicals, with no international revenue disclosed.
  • There are no immediate signs of equity dilution, and the company's risk profile remains stable.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$8.33B
Gross profit$2.35B
Operating income$1.58B
Net income$1.26B
R&D
SG&A
D&A
SBC
Operating cash flow$641.9M
CapEx-$369.8M
Free cash flow$520.2M
Total assets$13.74B
Total liabilities$6.03B
Total equity$7.71B
Cash & equivalents
Long-term debt$3.05B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$8.33B$1.58B$1.26B$520.2M
FY-1$5.91B$1.18B$956.5M$271.2M
FY-2$4.32B$967.4M$766.4M-$183.5M
FY-3$3.45B$964.8M$758.7M-$1.04B
FY-4$2.53B$437.8M$367.8M-$1.46B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$13.74B$7.71B
FY-1$12.92B$6.17B
FY-2$12.02B$5.76B
FY-3$10.15B$4.38B
FY-4$6.92B$3.56B
PeriodOCFCapExFCFSBC
FY0$641.9M-$369.8M$520.2M
FY-1$859.2M-$451.9M$271.2M
FY-2$528.4M-$803.7M-$183.5M
FY-3$543.7M-$1.80B-$1.04B
FY-4$80.5M-$1.92B-$1.46B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.82B$243.9M$188.6M
FQ-1$2.52B$387.2M$295.7M
FQ-2$2.44B$533.9M$428.6M
FQ-3$1.87B$416.4M$334.0M
FQ-4$1.49B$256.7M$202.0M
FQ-5$1.93B$339.9M$284.3M
FQ-6$1.49B$409.0M$318.5M
FQ-7$1.44B$282.6M$219.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$13.62B$7.92B$1.62B
FQ-1$13.74B$7.71B
FQ-2$13.38B$7.39B$898.9M
FQ-3$13.36B$6.77B
FQ-4$12.93B$6.37B$1.72B
FQ-5$12.92B$6.17B
FQ-6$12.81B$5.89B$1.94B
FQ-7$11.37B$5.57B
PeriodOCFCapExFCFSBC
FQ0-$592.6M-$148.2M
FQ-1$641.9M-$369.8M
FQ-2$42.1M-$305.3M
FQ-3-$147.3M-$230.9M
FQ-4-$298.5M-$145.7M
FQ-5$859.2M-$451.9M
FQ-6$438.1M-$327.9M
FQ-7$148.0M-$196.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.71B
Net cash-$3.05B
Current ratio1.1
Debt/Equity0.4
ROA9.2%
ROE16.4%
Cash conversion51.0%
CapEx/Revenue-4.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002895Activity
Op margin19.0%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin15.1%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin28.2%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity40.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target45.87 CNY
Median price target47.34 CNY
High price target50.30 CNY
Low price target39.97 CNY
Mean recommendation1.60 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.46 CNY
Last actual EPS2.19 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:32 UTCJob: d61cdf2f